| #124 |
Richard Arhart |
E.I. Du Pont De Nemours And |
1 |
| #124 |
Noel M. Hasty |
E.I. Du Pont De Nemours And |
1 |
| #124 |
Kevin R. Gerzevske |
Ciba Specialty Chemicals |
1 |
| #124 |
Douglas Brian Jordan |
E.I. Du Pont De Nemours And |
1 |
| #124 |
William S. Carey |
Betz Laboratories |
1 |
| #124 |
Kelly Parker |
Air Lift |
1 |
| #124 |
Stephen Claude De La Veaux |
E.I. Du Pont De Nemours And |
1 |
| #124 |
Paul B. Smart |
— |
1 |
| #124 |
Xiao Hong |
JPMorgan Chase |
1 |
| #124 |
Bryan Benedict Sauer |
E.I. Du Pont De Nemours And |
1 |
| #124 |
Bruce H. Stanley |
E.I. Du Pont De Nemours And |
1 |
| #124 |
Thomas Haws |
Aventis Pharmaceuticals |
1 |
| #124 |
Phil Edwards |
Astrazeneca Ab |
1 |
| #124 |
Lihong Shen |
Astrazeneca Ab |
1 |
| #124 |
John J. Scanlon |
Alloy Surfaces Company |
1 |
| #124 |
Tracy M. Pletz |
JPMorgan Chase |
1 |
| #124 |
Pierre E. Rouviere |
E.I. Du Pont De Nemours And |
1 |
| #124 |
Katia Sol-Church |
The Nemours Foundation |
1 |
| #124 |
David M Mellen |
E.I. Du Pont De Nemours And |
1 |
| #124 |
Dalen E. Keys |
E.I. Du Pont De Nemours And |
1 |
| #124 |
Gerald Graves |
Charles Schwab & Co. |
1 |
| #124 |
Richard E. Godwin |
E.I. Du Pont De Nemours And |
1 |
| #124 |
Louis G. Rosanio, Jr. |
E.I. Du Pont De Nemours And |
1 |
| #124 |
Frank Leonard Schadt, III |
E.I. Du Pont De Nemours And |
1 |
| #124 |
Derek Edwards |
ICI |
1 |